CEPH Related Hot M&A

May 2, 2011 07:00 AM Teva (TEVA) to acquire Cephalon (CEPH) for $81.50/share; deal valued at $6.8 billion

Apr 5, 2011 06:39 PM Cephalon (CEPH) Rejects Valeant's (VRX) $73/Share Offer

Mar 29, 2011 05:34 PM Valeant (VRX) Makes $5.7B Bid for Cephalon (CEPH)

Mar 29, 2011 05:32 PM Valeant Pharma (VRX) proposes to buy Cephalon (CEPH) for $73 per share